DSIN, Ranbaxy & RSC meet on 'Overcoming the Bottlenecks in Drug Discovery and Development'

摘要

DAIICHI Sankyo India Pharma Pvt. Ltd. (DSIN) and Ranbaxy Laboratories Ltd (Ranbaxy) together with the Royal Society of Chemistry (RSC) organized a symposium titled "Overcoming the Bottlenecks in Drug Discovery and Development" in Gurgaon on March 20 & 21, 2014. The two-day symposium was attended by over 400 delegates from many countries including, India, Japan, USA, UK, Singapore and featured lectures from leading researchers on four key pharmaceutical R&D themes: 1. Biological hit identification 2. Chemical hit identification 3. Pharmaceutical research 4. Chemical hit to lead optimization.